Senilidade ocular
DOI:
https://doi.org/10.11606/issn.2176-7262.rmrp.2022.187015Palavras-chave:
Envelhecimento, Catarata, Glaucoma, Degeneração Macular, CegueiraResumo
O processo de envelhecimento do olho está associado ao desenvolvimento de diversas condições patológicas que resultam em perda visual. Este artigo aborda três doenças que figuram entre as principais causas de cegueira na população mundial: catarata, glaucoma e degeneração macular relacionada à idade.
Downloads
Referências
Arieta CEL. Cristalino e Catarata / Conselho Brasileiro de Oftalmologia. 4 ed. Alex MR (ed.) Rio de Janeiro: Cultura Medica; 2018.
Jick SL, Beardsley TL, Brasington CR, Buznego C, Grostern RJ, Park L, et al. Basic and Clinical Science Course: Lens and Cataract. São Franciso: American Academy of Ophthalmology; 2019.
Adelson JD, Bourne RRA, Briant PS, Flaxman SR, Taylor HRB, Jonas JB, et al. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. The Lancet Global Health. [Online] 2020; Available from: doi:10.1016/S2214-109X(20)30489-7
Bourne R, Steinmetz JD, Flaxman S, Briant PS, Taylor HR, Resnikoff S, et al. Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study. The Lancet Global Health. [Online] 2020; Available from: doi:10.1016/S2214-109X(20)30425-3
Resnikoff S, Pascolini D, Etya’ale D, Kocur I, Pararajasegaram R, Pokharel GP, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004;82(11): 844–851.
Furtado JM, Berezovsky A, Ferraz NN, Muñoz S, Fernandes AG, Watanabe SS, et al. Prevalence and Causes of Visual Impairment and Blindness in Adults Aged 45 Years and Older from Parintins: The Brazilian Amazon Region Eye Survey. Ophthalmic Epidemiology. [Online] 2019;26(5). Available from: doi:10.1080/09286586.2019.1624783
Salomão SR, Cinoto RW, Berezovsky A, Araüjo-Filho A, Mitsuhiro MRKH, Mendieta L, et al. Prevalence and Causes of Vision Impairment and Blindness in Older Adults in Brazil: The São Paulo Eye Study. Ophthalmic Epidemiology. [Online] 2008;15(3). Available from: doi:10.1080/09286580701843812
Schellini SA, Durkin SR, Hoyama E, Hirai F, Cordeiro R, Casson RJ, et al. Prevalence and causes of visual impairment in a Brazilian population: The Botucatu Eye Study. BMC Ophthalmology. [Online] 2009;9(1). Available from: doi:10.1186/1471-2415-9-8
Leite Arieta CE, de Oliveira DF, de Carvalho Lupinacci AP, Novaes P, Paccola M, Jose NK, et al. Cataract Remains an Important Cause of Blindness in Campinas, Brazil. Ophthalmic Epidemiology. [Online] 2009;16(1). Available from: doi:10.1080/09286580802575032
Klein R, Lee KE, Gangnon RE, Klein BEK. Relation of Smoking, Drinking, and Physical Activity to Changes in Vision over a 20-Year Period. Ophthalmology. [Online] 2014;121(6). Available from: doi:10.1016/j.ophtha.2014.01.003
Ye J, He J, Wang C, Wu H, Shi X, Zhang H, et al. Smoking and Risk of Age-Related Cataract: A Meta-Analysis. Investigative Opthalmology & Visual Science. [Online] 2012;53(7). Available from: doi:10.1167/iovs.12-9820
Girkin CA, Bhorade AM, Crowston JG, Giaconi JA, Medeiro FA, Sit AJ, et al. Basic and Clinical Science Course: Glaucoma . São Francisco: American Academy of Ophthalmology; 2019.
Mello PA de A, Susanna Jr R, Almeida HG de. Glaucoma / Conselho Brasileiro de Oftalmologia.. 4 ed. Alves MR (ed.) Rio de Janeiro : Cultura Medica ; 2016.
Tham Y-C, Li X, Wong TY, Quigley HA, Aung T, Cheng C-Y. Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040. Ophthalmology. [Online] 2014;121(11). Available from: doi:10.1016/j.ophtha.2014.05.013
Sakata K, Sakata LM, Sakata VM, Santini C, Hopker LM, Bernardes R, et al. Prevalence of Glaucoma in a South Brazilian Population: Projeto Glaucoma. Investigative Opthalmology & Visual Science. [Online] 2007;48(11). Available from: doi:10.1167/iovs.07-0342
Jonas JB, Aung T, Bourne RR, Bron AM, Ritch R, Panda-Jonas S. Glaucoma. The Lancet. [Online] 2017;390(10108). Available from: doi:10.1016/S0140-6736(17)31469-1
Vaconcellos JPC, Sakata LM, da Silva MJL, Costa VP. II Consenso de glaucoma de ângulo fechado. Sociedade Brasileira de Glaucoma; 2012.
de Moraes CG, Liebmann JM, Greenfield DS, Gardiner SK, Ritch R, Krupin T. Risk Factors for Visual Field Progression in the Low-pressure Glaucoma Treatment Study. American Journal of Ophthalmology. [Online] 2012;154(4). Available from: doi:10.1016/j.ajo.2012.04.015
Peters D, Bengtsson B, Heijl A. Lifetime Risk of Blindness in Open-Angle Glaucoma. American Journal of Ophthalmology. [Online] 2013;156(4). Available from: doi:10.1016/j.ajo.2013.05.027
Ratnapriya R, Chew EY. Age‐related macular degeneration—clinical review and genetics update. Clinical Genetics. [Online] 2013;84(2). Available from: doi:10.1111/cge.12206
Bressler NM. Age-Related Macular Degeneration Is the Leading Cause of Blindness . JAMA. [Online] 2004;291(15). Available from: doi:10.1001/jama.291.15.1900
Alves MR, Avila M, Lavinsky J, Moreira Junior CA, editors. Retina e vítreo / Conselho Brasileiro de Oftalmologia .. 4.ed. Rio de Janeiro: Cultura Médica; 2016.
A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation With Vitamins C and E, Beta Carotene, and Zinc for Age-Related Macular Degeneration and Vision Loss. Archives of Ophthalmology. [Online] 2001;119(10). Available from: doi:10.1001/archopht.119.10.1417
Bressler SB. Introduction: Understanding the Role of Angiogenesis and Antiangiogenic Agents in Age-Related Macular Degeneration. Ophthalmology. [Online] 2009;116(10). Available from: doi:10.1016/j.ophtha.2009.06.045
Ciulla TA, Rosenfeld PJ. Antivascular endothelial growth factor therapy for neovascular age-related macular degeneration. Current Opinion in Ophthalmology. [Online] 2009;20(3). Available from: doi:10.1097/ICU.0b013e32832d25b3
Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, et al. Ranibizumab for Neovascular Age-Related Macular Degeneration. New England Journal of Medicine. [Online] 2006;355(14). Available from: doi:10.1056/NEJMoa054481
Schmidt-Erfurth U, Kaiser PK, Korobelnik J-F, Brown DM, Chong V, Nguyen QD, et al. Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration. Ophthalmology. [Online] 2014;121(1). Available from: doi:10.1016/j.ophtha.2013.08.011
Li X, Xu G, Wang Y, Xu X, Liu X, Tang S, et al. Safety and Efficacy of Conbercept in Neovascular Age-Related Macular Degeneration. Ophthalmology. [Online] 2014;121(9). Available from: doi:10.1016/j.ophtha.2014.03.026
Rosenfeld PJ, Moshfeghi AA, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging. 2005;Jul-Aug(4): 331–335.
Downloads
Publicado
Edição
Seção
Licença
Copyright (c) 2022 Bruna Melchior, Leticia Barroso, Thaís Marino de Azeredo Bastos, Italo Pena de Oliveira, Rodrigo Jorge , Jayter Silva Paula
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
